Papadaki, C.; Monastirioti, A.; Rounis, K.; Makrakis, D.; Kalbakis, K.; Nikolaou, C.; Mavroudis, D.; Agelaki, S.
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy. Cancers 2020, 12, 1282.
https://doi.org/10.3390/cancers12051282
AMA Style
Papadaki C, Monastirioti A, Rounis K, Makrakis D, Kalbakis K, Nikolaou C, Mavroudis D, Agelaki S.
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy. Cancers. 2020; 12(5):1282.
https://doi.org/10.3390/cancers12051282
Chicago/Turabian Style
Papadaki, Chara, Alexia Monastirioti, Konstantinos Rounis, Dimitrios Makrakis, Konstantinos Kalbakis, Christoforos Nikolaou, Dimitrios Mavroudis, and Sofia Agelaki.
2020. "Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy" Cancers 12, no. 5: 1282.
https://doi.org/10.3390/cancers12051282
APA Style
Papadaki, C., Monastirioti, A., Rounis, K., Makrakis, D., Kalbakis, K., Nikolaou, C., Mavroudis, D., & Agelaki, S.
(2020). Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy. Cancers, 12(5), 1282.
https://doi.org/10.3390/cancers12051282